Advanced Medical Solutions Group Regulatory News (AMS)

11 Oct 2006 07:00

Advanced Medical Solutions Grp PLC11 October 2006 For immediate release 11 October 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") FDA clears surgical skin sealant for sale in US Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces that Kimberly-Clark* Integuseal*Microbial Sealant has received 510(k) clearance by the Food & DrugAdministration (FDA) allowing it to be marketed in the US. Kimberly-Clark* Integuseal* Microbial Sealant is used to reduce the risk of skinflora contamination throughout a surgical procedure, a key factor in thedevelopment of surgical site infections which occur in 2-5% of all surgicalprocedures. This can lead to serious complications and increased morbidity tothe patient and significant incremental costs to health care providers. It isgenerally accepted that contamination by the patient's endogenous skin flora isa key factor in the development of surgical site infections and despite standardpreventative steps, these remain an issue of concern. Based upon patented cyanoacrylate technology, AMS has developed an innovativefilm-forming solution that bonds to the skin sealing off the spaces wherebacteria can grow and immobilises endogenous pathogens thereby reducing the riskof skin flora contamination. A novel applicator has been developed that allows the solution to be effectivelyapplied even on irregular and contoured areas of the body, such as shoulders andknees, which are generally difficult to drape. Easy to apply and fast-drying,Kimberly-Clark* Integuseal* Microbial Sealant can be used in conjunction with avariety of preparatory treatments and surgical products such as electrocautery,sutures, staples and wound adhesives. In March 2006 AMS announced that it had entered into a strategic partnershipwith Kimberly-Clark Health Care who would have exclusive rights to market anddistribute this technology in all global markets under its brand Kimberly-Clark*Integuseal* Microbial Sealant. Atlanta based Kimberly-Clark Health Care is anover $1 billion turnover business unit within the global Kimberly-ClarkCorporation. It manufactures and markets a wide range of surgical products andis a leader in several medical device categories. Commenting on today's announcement Dr. Don Evans, Chief Executive of AMS stated: "We are delighted that Kimberly-Clark* Integuseal* Microbial Sealant has nowbeen cleared for sale into the US. The product has already been cleared andlaunched into the EU and other geographies and this allows entry into theworld's biggest market during 2007. "Kimberly-Clark Health Care's strong presence and focus on infection control inthe Operating Room make it an ideal partner for rapid commercialisation of thisexciting new technology." -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS's technology and products currently serve the majority of the key globalmarkets and strategic partners. Kimberly-Clark in the Healthcare Environment Around the world, medical professionals turn to Kimberly-Clark for a wideportfolio of solutions that improve the health, hygiene and well-being of theirpatients and staff. As part of their healing mission, caregivers rely onKimberly-Clark to deliver clinical solutions and educational resources that theycan depend on to prevent, diagnose and manage a wide variety ofhealthcare-associated infections. This over $1 billion global enterprise of Kimberly-Clark Corporation holds theNo. 1 and No. 2 market share positions in several categories including infectioncontrol solutions, surgical solutions, pain management and digestive health. Andthroughout the care continuum, patients and staff alike trust Kimberly-Clark*medical supplies and devices, KLEENEX* tissues, KIMBERLY-CLARK* professionalskin care products, and SCOTT* towels for day-to-day needs. For more information, please visit http://www.kchealthcare.com. * Registered Trademark or Trademark of Kimberly-Clark Worldwide, Inc. (c) 2006KCWW. This information is provided by RNS The company news service from the London Stock Exchange